Top Markets
Coin of the day
Brickell Biotech, Inc. Brickell Biotech, Inc.

Brickell Biotech, Inc.

BBI
Rangering i aksjer #40377
Brickell Biotech, Inc. is a pharmaceutical company currently in the clinical... Brickell Biotech, Inc. is a pharmaceutical company currently in the clinical development phase, dedicated to creating prescription medicines for various debilitating conditions, including autoimmune and inflammatory disorders, primarily within the United States. Its product pipeline includes sofpironium bromide, which has successfully finished Phase III clinical trials for treating excessive underarm sweating (primary axillary hyperhidrosis). Other notable candidates are BBI-02, an oral DYRK1A inhibitor targeting autoimmune and inflammatory diseases, and BBI-10, a covalent stimulator of interferon genes (STING) inhibitor, being explored for autoinflammatory and rare genetic illnesses. The company is also advancing next-generation kinase inhibitors. Brickell Biotech collaborates with several partners, such as Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. Established in 2009, its main office is located in Boulder, Colorado.
Aksjekurs
$2.35
Sist synkronisert: 2022-09-07
Markedsverdi
$162.94K
Endring (1 dag)
2.17%
Endring (1 år)
0.00%
Land
US
Handel Brickell Biotech, Inc. (BBI)

Kategori

Pris BBI pris med markedsverdi på B
Brickell Biotech, Inc. Brickell Biotech, Inc.
BBI
$2.35
Markedsverdi av Brickell Biotech, Inc.(BBI)
Markedsverdi: $162.94K
Per August 2026 har Brickell Biotech, Inc. en markedsverdi på $162.94K. Dette gjør Brickell Biotech, Inc. til det 40377th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Brickell Biotech, Inc. fra 2019 til 2026
BBI sammenlignet med topp 5 mest populære stocks
Pris på BBI Eiendel B Markedsverdi for B Resultater
Brickell Biotech, Inc. Brickell Biotech, Inc.
$78,884,530 $162.94K
$5.470T +3,356,788,414.27%
Brickell Biotech, Inc. Brickell Biotech, Inc.
$64,426,434 $162.94K
$4.467T +2,741,550,267.91%
Brickell Biotech, Inc. Brickell Biotech, Inc.
$60,205,180 $162.94K
$4.174T +2,561,922,456.83%
Brickell Biotech, Inc. Brickell Biotech, Inc.
$53,364,447 $162.94K
$3.700T +2,270,827,439.47%
Brickell Biotech, Inc. Brickell Biotech, Inc.
$41,166,821 $162.94K
$2.854T +1,751,779,516.19%